Related Research Articles
Schizophrenia is a mental disorder characterized by continuous or relapsing episodes of psychosis. Major symptoms include hallucinations, delusions and disorganized thinking. Other symptoms include social withdrawal and flat affect. Symptoms typically develop gradually, begin during young adulthood, and in many cases are never resolved. There is no objective diagnostic test; diagnosis is based on observed behavior, a psychiatric history that includes the person's reported experiences, and reports of others familiar with the person. For a diagnosis of schizophrenia, the described symptoms need to have been present for at least six months or one month. Many people with schizophrenia have other mental disorders, especially substance use disorders, depressive disorders, anxiety disorders and obsessive–compulsive disorder.
Psychiatric epidemiology is a field which studies the causes (etiology) of mental disorders in society, as well as conceptualization and prevalence of mental illness. It is a subfield of the more general epidemiology. It has roots in sociological studies of the early 20th century. However, while sociological exposures are still widely studied in psychiatric epidemiology, the field has since expanded to the study of a wide area of environmental risk factors, such as major life events, as well as genetic exposures. Increasingly neuroscientific techniques like MRI are used to explore the mechanisms behind how exposures to risk factors may impact psychological problems and explore the neuroanatomical substrate underlying psychiatric disorders.
Psychiatric genetics is a subfield of behavioral neurogenetics and behavioral genetics which studies the role of genetics in the development of mental disorders. The basic principle behind psychiatric genetics is that genetic polymorphisms are part of the causation of psychiatric disorders.
Calcium channel, voltage-dependent, L type, alpha 1C subunit is a protein that in humans is encoded by the CACNA1C gene. Cav1.2 is a subunit of L-type voltage-dependent calcium channel.
Peter McGuffin is a psychiatrist and geneticist from Belfast, Northern Ireland.
Risk factors of schizophrenia include many genetic and environmental phenomena. The prevailing model of schizophrenia is that of a special neurodevelopmental disorder with no precise boundary or single cause. Schizophrenia is thought to develop from very complex gene–environment interactions with vulnerability factors. The interactions of these risk factors are intricate, as numerous and diverse medical insults from conception to adulthood can be involved. The combination of genetic and environmental factors leads to deficits in the neural circuits that affect sensory input and cognitive functions. Historically, this theory has been broadly accepted but impossible to prove given ethical limitations. The first definitive proof that schizophrenia arises from multiple biological changes in the brain was recently established in human tissue grown from patient stem cells, where the complexity of disease was found to be "even more complex than currently accepted" due to cell-by-cell encoding of schizophrenia-related neuropathology.
Potassium voltage-gated channel subfamily V member 1 is a protein that in humans is encoded by the KCNV1 gene. The protein encoded by this gene is a voltage-gated potassium channel subunit.
Glyn Lewis is a British professor of psychiatric epidemiology and the current head of the Division of Psychiatry at University College London
The imprinted brain hypothesis is an unsubstantiated hypothesis in evolutionary psychology regarding the causes of autism spectrum and schizophrenia spectrum disorders, first presented by Bernard Crespi and Christopher Badcock in 2008. It claims that certain autistic and schizotypal traits are opposites, and that this implies the etiology of the two conditions must be at odds.
Joseph D. Buxbaum is an American molecular and cellular neuroscientist, autism researcher, and the Director of the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai. Buxbaum is also, along with Simon Baron-Cohen, the co-editor of the BioMed Central journal Molecular Autism, and is a member of the scientific advisory board of the Autism Science Foundation. Buxbaum is a Professor of Psychiatry, Neuroscience, and Genetics and Genomic Sciences. He is also the Vice Chair for Research and for Mentoring in the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai.
Cathryn Lewis is Professor of Genetic Epidemiology and Statistics at King's College London. She is Head of Department at the Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience.
Sir Michael John Owen FRCPsych FMedSci FLSW is a Welsh research scientist in the area of psychiatry, currently the head of the Division of Psychological Medicine and Clinical Neurosciences at Cardiff University.
Pamela Sklar was an American psychiatrist and neuroscientist. She was Chair of the Department of Genetics and Genomic Sciences and professor of psychiatry, neuroscience, and genetic and genomic sciences at the Icahn School of Medicine at Mount Sinai. She was also chief of the Division of Psychiatric Genomics at the Icahn School of Medicine at Mount Sinai. Sklar is known for her large-scale gene discovery studies in bipolar disorder and schizophrenia and for making some of the first statistically meaningful gene identifications in both mental illnesses.
The Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard is a multi-disciplinary biomedical research program located in Cambridge, Massachusetts that studies the biological basis of psychiatric disease.
Li Tao is a Chinese academic psychiatrist. She is the dean of the Mental Health Center affiliated to Zhejiang University School of Medicine. She is a clinician, professor, and researcher, specialising in topics relating to molecular genetics and mental illness.
In genetics, a polygenic score (PGS) is a number that summarizes the estimated effect of many genetic variants on an individual's phenotype. The PGS is also called the polygenic index (PGI) or genome-wide score; in the context of disease risk, it is called a polygenic risk score or genetic risk score. The score reflects an individual's estimated genetic predisposition for a given trait and can be used as a predictor for that trait. It gives an estimate of how likely an individual is to have a given trait based only on genetics, without taking environmental factors into account; and it is typically calculated as a weighted sum of trait-associated alleles.
Ming Tso Tsuang is an American psychiatrist and Distinguished Professor of Psychiatry at the University of California, San Diego. He is considered a pioneering researcher in the genetic epidemiology of schizophrenia and other severe mental disorders. Tsuang has authored and co-authored more than 600 publications and serves as founding and senior editor of the American Journal of Medical Genetics Part B.
Jordan Wassertheil Smoller is an American psychiatric geneticist. He is Professor of Psychiatry at Harvard Medical School and a Professor in the Department of Epidemiology at the Harvard School of Public Health. He also serves as Trustees Endowed Chair in Psychiatric Neuroscience and Director of the Psychiatric and Neurodevelopmental Genetics Unit at Massachusetts General Hospital. His other positions include being an associate member of the Broad Institute, vice president of the International Society of Psychiatric Genetics, and co-chair of the Cross Disorder Group of the Psychiatric Genomics Consortium. His laboratory at Massachusetts General Hospital, a division of the Psychiatric and Neurodevelopmental Genetics Unit, aims to determine the genetic basis of psychiatric disorders in both children and adults. In 2013, he was the lead author of a study examining genetic loci associated with an increased risk of five psychiatric disorders. Smoller is the son of Sylvia Wassertheil-Smoller.
The Psychiatric Genomics Consortium (PGC) is an international consortium of scientists dedicated to conducting meta- and mega-analyses of genomic-wide genetic data, with a focus on psychiatric disorders. It is the largest psychiatric consortium ever created, including over 800 researchers from 38 countries as of 2019. Its goal is to generate information about the genetics of psychiatric conditions that will be "actionable", that is, "genetic findings whose biological implications can be used to improve diagnosis, develop rational therapeutics, and craft mechanistic approaches to primary prevention". The consortium makes the main findings from its research freely available for use by other researchers.
René Sylvain Kahn is a neuropsychiatrist and the Esther and Joseph Klingenstein Professor and System Chair of Psychiatry at the Icahn School of Medicine at Mount Sinai in the United States, a position he has held since 2017. He previously served as Professor of Psychiatry and Director of the Brain Center Rudolf Magnus at the University Medical Center Utrecht in the Netherlands. Kahn is recognized for his research on the neurobiology of schizophrenia. He served as a former president of the Schizophrenia International Research Society and was elected to the Royal Netherlands Academy of Arts and Sciences in 2009. He received the Neuropsychopharmacology Award from the European College of Neuropsychopharmacology in 2014.
References
- ↑ Owen, Michael; O'Donovan, Michael (1 October 2005). "Genetics of schizophrenia". Psychiatry. 4 (10): 14–17. doi:10.1383/psyt.2005.4.10.14. ISSN 1476-1793. PMC 2793225 . PMID 20008600.
- ↑ "Past Outstanding Achievement Prizewinners". Brain & Behavior Research Foundation . 11 April 2017. Retrieved 14 December 2018.
- ↑ Burns, Janice (3 June 2015). "Scots gene expert at forefront of fight to understand causes of schizophrenia". The National . Retrieved 14 December 2018.
- ↑ O’Donovan, Michael (5 August 2015). "Novel genetic advances in schizophrenia: an interview with Michael O'Donovan". BMC Medicine . 13 (1): 181. doi: 10.1186/s12916-015-0417-1 . ISSN 1741-7015. PMC 4526195 . PMID 26242973.
- ↑ "Workgroup Chairs". Psychiatric Genomics Consortium.
- ↑ "Professor Mick O'Donovan". National Centre for Mental Health. Retrieved 14 December 2018.
- ↑ O’Donovan, Michael C.; Sullivan, Patrick F.; Daly, Mark J.; Werge, Thomas; Wendland, Jens R.; Weinberger, Daniel R.; Clair, David St; Sklar, Pamela; Sham, Pak C. (July 2014). "Biological insights from 108 schizophrenia-associated genetic loci". Nature . 511 (7510): 421–427. Bibcode:2014Natur.511..421S. doi:10.1038/nature13595. ISSN 1476-4687. PMC 4112379 . PMID 25056061.
- ↑ McCarthy, James (27 July 2014). "Welsh scientist leading global research into schizophrenia speaks of hopes for the millions affected by the illness". Media Wales . Retrieved 14 December 2018.
- ↑ "New clues to schizophrenia cause". BBC News . 22 July 2014. Retrieved 14 December 2018.
- ↑ Borenstein, Seth (22 July 2014). "Genetic mapping triggers new hope on schizophrenia". The News-Herald . Retrieved 14 December 2018.
